LB Pharmaceuticals

tenant

trial

Social Cognition in Longstanding Psychosis

NCTId NCT01624831

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Terminated

Enrollment 9 (actual)

Sponsored by University of Arizona

Primary completion 2015-11

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Terminated

Enrollment

9 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2011-11

Primary completion

2015-11

Eligibility

ALL · 18 Years · 75 Years

Interventions & indications

Drugs

—

Indications

Schizoaffective Disorder Psychotic Disorders Schizophrenia Bipolar Disorder With Psychotic Features Psychosis Not Otherwise Specified (NOS)Schizophrenia Major Depression With Psychotic Features Mental Disorders

Sponsors

University of ArizonaLead Sponsor

Investigators

1

Nicholas Breitborde, Ph.D.Principal Investigator

Sites

1 total

Tucson, United States

Facts & assertions

4 sourced

Enrollment

9

Phase

NA

Primary Completion Date

2015-11

Status

TERMINATED

relationships

The graph out of here

lead_sponsor

University of Arizona

company

indication

Schizoaffective Disorder

indication

Psychotic Disorders

indication

indication

investigator

Nicholas Breitborde, Ph.D.

person